Skip to main content
. Author manuscript; available in PMC: 2015 Aug 18.
Published in final edited form as: Angiogenesis. 2014 Feb 26;17(3):661–673. doi: 10.1007/s10456-014-9422-9

Fig. 2.

Fig. 2

As previously reported [13], a combination of metronomic topotecan and pazopanib inhibited progression of metastatic disease in mice implanted with the SKOV-3-13 cell line. However, mice implanted with variants −7SD or −7AS and treated with the same combination chemotherapy, showed a shorter median survival (n = 5 mice for all groups, Kaplan–Meier P < 0.05 taken as statistical indication of difference between parental and 7AS and 7SD)